Search for: "MYLAN TECHNOLOGIES INC." Results 21 - 40 of 149
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
16 Jun 2022, 9:15 am by Jonathan Stroud
Among those cases, note: Peter Pedersen has continued to add defendants to what promises to be a wide-ranging assertion campaign based on a single patent covering organizing email lists; Samsung has settled a tranche of IPRs against Trenchant Blade Technologies (associated with Tanit Ventures, Inc., with old patents, presumably with a backend, from Taiwan Semiconductor Manufacturing Corporation TSMC); Google filed more inter partes reviews (IPRs) against Jawbone (the failed company… [read post]
7 Aug 2009, 6:15 am
Law firms are filing more fentanyl pain patch lawsuitsâ€â [read post]
1 Mar 2013, 6:28 am by Gene Quinn
Related posts:Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
1 Sep 2014, 7:04 am
Entries should be emailed to katcontest1@gmail.com by Monday 8 September 11 pm GMT. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
13 Mar 2019, 9:10 am by Dennis Crouch
Mylan Pharmaceuticals, Inc., et al., No. 18-899 (May tribal sovereign immunity may be asserted to bar IPR review of patents owned by the tribe?) [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
5 Jul 2020, 10:30 am by Magdaleen Jooste
Court of Appeals for the Federal Circuit (CAFC) affirmed a Patent Trial and Appeal Board (PTAB) decision that certain claims of Nike, Inc. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against Wockhardt… [read post]
The following consumer protection actions made headlines this week: Mylan Reaches $465 Million Settlement Over Medicaid Classification On October 7, 2016, Mylan Inc. announced that it had agreed to pay $465 million to resolve a DOJ investigation into Mylan’s classification of EpiPen as a generic drug that resulted in Medicaid and Medicare receiving a significantly smaller rebate on every prescription since 2007. [read post]
14 Dec 2021, 9:57 am by Dennis Crouch
VLSI Technology LLC (Follow-on case to Mylan v. [read post]
6 Apr 2020, 6:47 am by Deb Givens
Many of Apple’s rivals in streaming music and video, such as Netflix Inc and Spotify Technology SA, avoid paying those commissions by asking users to sign up with a credit card outside the App Store. [read post]